Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.

Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
复制标题

DOI:
10.18632/oncotarget.10520
复制
发表时间:
2016-08-23
期刊:
影响因子:
--
通讯作者:
Davuluri RV
Davuluri RV
中科院分区:
其他
文献类型:
--
作者:
Jin HJ;Jung S;DebRoy AR;Davuluri RV

文献摘要

被引文献

相似文献

前列腺癌(PCa)是美国男性癌症相关死亡的第二大常见实体瘤。全基因组关联研究(GWAS)已经确定了与PCa风险增加相关的单核苷酸多态性(SNP)。由于大多数易感性SNPs位于非编码区,对其功能机制知之甚少。我们假设功能性SNP存在于细胞类型特异性调控元件中,这些元件介导关键转录因子(TF)的结合,进而导致靶基因表达的变化。使用PCa特异性功能基因组学数据,在这里,我们确定了PCa中的38个调控候选SNP及其靶基因。通过结合基因表达和临床数据的风险分析,我们确定了6个靶基因(ZG 16 B,ANKRD 5,RERE,FAM 96 B,NAALADL 2和GTPBP 10)作为PCa生化复发的重要预测因子。此外,选择5个SNP(rs 2659051、rs 10936845、rs 9925556、rs6057110和rs 2742624)用于在LNCaP细胞中使用染色质免疫沉淀(ChIP)、双荧光素酶报告基因测定的实验验证,显示等位基因特异性增强子活性。此外,我们使用CRISPR/Cas9基因组编辑删除了含有rs 2742624的区域,并观察到其靶基因UPK 3A的大幅下调。总之,我们的研究结果表明,这种新的方法可以应用于识别可能影响PCa风险的调节SNP及其靶基因。我们认为,可以进行类似的研究,以表征其他疾病中的调节变异。
Prostate cancer (PCa) is the second most common solid tumor for cancer related deaths in American men. Genome wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) associated with the increased risk of PCa. Because most of the susceptibility SNPs are located in noncoding regions, little is known about their functional mechanisms. We hypothesize that functional SNPs reside in cell type-specific regulatory elements that mediate the binding of critical transcription factors (TFs), which in turn result in changes in target gene expression. Using PCa-specific functional genomics data, here we identify 38 regulatory candidate SNPs and their target genes in PCa. Through risk analysis by incorporating gene expression and clinical data, we identify 6 target genes (ZG16B, ANKRD5, RERE, FAM96B, NAALADL2 and GTPBP10) as significant predictors of PCa biochemical recurrence. In addition, 5 SNPs (rs2659051, rs10936845, rs9925556, rs6057110 and rs2742624) are selected for experimental validation using Chromatin immunoprecipitation (ChIP), dual-luciferase reporter assay in LNCaP cells, showing allele-specific enhancer activity. Furthermore, we delete the rs2742624-containing region using CRISPR/Cas9 genome editing and observe the drastic downregulation of its target gene UPK3A. Taken together, our results illustrate that this new methodology can be applied to identify regulatory SNPs and their target genes that likely impact PCa risk. We suggest that similar studies can be performed to characterize regulatory variants in other diseases.